These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 33555151)

  • 21. Predicting the Speed of Response to Omalizumab in Chronic Spontaneous Urticaria.
    Keskinkaya Z; Kaya Ö; Işık Mermutlu S; Öğretmen Z
    Int Arch Allergy Immunol; 2024; 185(8):786-793. PubMed ID: 38626739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlations between disease activity, autoimmunity and biological parameters in patients with chronic spontaneous urticaria.
    de Montjoye L; Darrigade AS; Giménez-Arnau A; Herman A; Dumoutier L; Baeck M
    Eur Ann Allergy Clin Immunol; 2021 Mar; 53(2):55-66. PubMed ID: 31965967
    [No Abstract]   [Full Text] [Related]  

  • 23. Hematologic parameters as biomarkers for antihistamine and omalizumab resistance in chronic spontaneous urticaria.
    Magen E; Waitman DA; Kahan NR
    Allergy Asthma Proc; 2021 Jan; 42(1):e17-e24. PubMed ID: 33404397
    [No Abstract]   [Full Text] [Related]  

  • 24. D-dimer levels decline after immunosuppressive treatment rather than anticoagulant treatment in severe autoimmune chronic spontaneous urticaria.
    Baskurt D; Sarac E; Asero R; Kocatürk E
    Eur Ann Allergy Clin Immunol; 2024 Jan; 56(1):42-44. PubMed ID: 36305339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study.
    Oztop N; Demir S; Unal D; Beyaz S; Terzioglu K; Olgac M; Gelincik A
    Allergy Asthma Proc; 2022 Nov; 43(6):519-528. PubMed ID: 36335414
    [No Abstract]   [Full Text] [Related]  

  • 26. Biomarkers to predict therapeutic response in chronic spontaneous urticaria: a review.
    Gimenez-Arnau AM; Salman A; Podder I
    Eur J Dermatol; 2024 Feb; 34(1):3-12. PubMed ID: 38557452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Omalizumab Treatment Response in Patients with Chronic Spontaneous Urticaria and Symptomatic Dermographism: A Single-Center Retrospective Study.
    Cakmak ME; Yeğit OO; Öztop N
    Int Arch Allergy Immunol; 2023; 184(3):236-242. PubMed ID: 36543155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Justification for IgE as a therapeutic target in chronic spontaneous urticaria.
    Sánchez-Borges M; Capriles-Hulet A; Caballero-Fonseca F; González-Aveledo L
    Eur Ann Allergy Clin Immunol; 2017 Jul; 49(4):148-153. PubMed ID: 28752717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omalizumab in chronic spontaneous and inducible urticaria: a 9 year retrospective study in Portugal.
    Marcelino J; Costa AC; Mendes A; Alonso E; Cabral Duarte F; Pedro E; Pereira-Barbosa M
    Eur Ann Allergy Clin Immunol; 2018 Jul; 50(4):169-176. PubMed ID: 29479938
    [No Abstract]   [Full Text] [Related]  

  • 30. Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab.
    MacGlashan D; Saini S; Schroeder JT
    J Allergy Clin Immunol; 2021 Jun; 147(6):2295-2304.e12. PubMed ID: 33716077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case Report: Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Crohn's Disease.
    Barni S; Giovannini M; Liccioli G; Sarti L; Gissi A; Lionetti P; Mori F
    Front Immunol; 2021; 12():635069. PubMed ID: 33737936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atopic status and thyroid autoimmunity do not predict omalizumab response in severe chronic spontaneous urticaria patients.
    Asero S
    Eur Ann Allergy Clin Immunol; 2024 May; 56(3):141-143. PubMed ID: 36786337
    [No Abstract]   [Full Text] [Related]  

  • 33. Omalizumab on Chronic Spontaneous Urticaria and Chronic Inducible Urticaria: A Real-World Study of Efficacy and Predictors of Treatment Outcome.
    Jeong SH; Lim DJ; Chang SE; Kim KH; Kim KJ; Park EJ
    J Korean Med Sci; 2022 Jul; 37(27):e211. PubMed ID: 35818702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers of Autoimmune Chronic Spontaneous Urticaria.
    Larenas-Linnemann D
    Curr Allergy Asthma Rep; 2023 Dec; 23(12):655-664. PubMed ID: 38064133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D-Dimer Plasma Levels Parallel the Clinical Response to Omalizumab in Patients with Severe Chronic Spontaneous Urticaria.
    Asero R; Marzano AV; Ferrucci S; Cugno M
    Int Arch Allergy Immunol; 2017; 172(1):40-44. PubMed ID: 28219067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of omalizumab treatment for pediatric chronic spontaneous urticaria: A multi-center retrospective case series.
    Ari A; Levy Y; Segal N; Maoz-Segal R; Benor S; Broides A; Horev A; Epstein-Rigbi N; Agmon-Levin N; Marcus N
    Pediatr Dermatol; 2020 Nov; 37(6):1051-1054. PubMed ID: 32951239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omalizumab in chronic spontaneous urticaria: Efficacy, safety, predictors of treatment outcome, and time to response.
    Nettis E; Cegolon L; Di Leo E; Lodi Rizzini F; Detoraki A; Canonica GW;
    Ann Allergy Asthma Immunol; 2018 Oct; 121(4):474-478. PubMed ID: 29949781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Omalizumab in Patients with Chronic Spontaneous Urticaria and Its Association with Serum IgE Levels and Eosinophil Count.
    Tamer F; Gulru Erdogan F; Dincer Rota D; Yildirim D; Akpinar Kara Y
    Acta Dermatovenerol Croat; 2019 Jun; 27(2):101-106. PubMed ID: 31351504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.
    Kaplan AP; Giménez-Arnau AM; Saini SS
    Allergy; 2017 Apr; 72(4):519-533. PubMed ID: 27861988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex differences in the efficacy of omalizumab in the treatment of chronic spontaneous urticaria.
    Sirufo MM; Bassino EM; De Pietro F; Ginaldi L; De Martinis M
    Int J Immunopathol Pharmacol; 2021; 35():20587384211065870. PubMed ID: 35170369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.